Plasma levels of activated FVII in various diseases.
Plasma activated factor VIIa (FVIIa) levels were measured in various diseases using mutant tissue factor (TF). FVIIa levels in thrombotic patients and patients with idiopathic thrombocytopenic purpura were significantly higher than those in healthy control subjects. The plasma FVIIa levels in thrombotic patients treated with warfarin were similar to those of control subjects. The plasma FVIIa levels in pregnant women and patients with systemic lupus erythematosus, infection or malignancies were high. However, the levels in patients with disseminated intravascular coagulation (DIC) were not significantly increased. DIC patients are in a severe hypercoagulable state, and exhibit severe consumption of coagulation factors. The slightly increased FVIIa level in the DIC patients observed is probably considered to be caused by consumption of coagulation factors. The plasma FVIIa level was poorly correlated with other hemostatic parameters except for protein C in our analysis of all cases. In the analysis of DIC and thrombotic patients treated without warfarin, the plasma FVIIa level was negatively correlated with TF antigen. Plasma FVIIa levels might reflect hypercoagulability in thrombotic diseases, and a normalized FVIIa level in patients with thrombotic diseases should be considered to be associated with DIC.
Yamada
A
A
2nd Department of Internal Medicine, Mie University School of Medicine, Japan.
Wada
H
H
Kamikura
Y
Y
Hiyoyama
K
K
Shimura
M
M
Nagaya
S
S
Deguchi
K
K
Mori
Y
Y
Shiku
H
H
D001327:Autoimmune Diseases / Q000097:blood*; D015415:Biomarkers; D003141:Communicable Diseases / Q000097:blood*; D015942:Factor VIIa / Q000032:analysis*; D005260:Female; D006402:Hematologic Diseases / Q000097:blood*; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000097:blood*; D011247:Pregnancy / Q000097:blood*
D015415:Biomarkers; D015942:Factor VIIa